Neurology Partnership Limited - Limited company - abbreviated - 11.9

Neurology Partnership Limited - Limited company - abbreviated - 11.9


SC209236 1.4.14 31.3.15 31.3.15 Company accounts Private Limited Company FY true false true false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureSC2092362014-03-31SC2092362015-03-31SC2092362014-04-012015-03-31SC2092362013-03-31SC2092362013-04-012014-03-31SC2092362014-03-31SC209236ns14:PoundSterling2014-04-012015-03-31SC209236ns7:Director12014-04-012015-03-31SC209236ns7:OrdinaryShareClass12014-04-012015-03-31SC209236ns7:Director22014-04-012015-03-31SC209236ns7:RegisteredOffice2014-04-012015-03-31SC209236ns7:EntityAccountantsOrAuditors2014-04-012015-03-31SC209236ns5:PlantMachinery2014-04-012015-03-31SC209236ns7:OrdinaryShareClass12015-03-31SC209236ns7:OrdinaryShareClass12014-03-31SC209236ns7:Director12014-03-31SC209236ns7:Director12013-03-31SC209236ns7:Director12013-04-012014-03-31SC209236ns7:Director12015-03-31SC209236ns7:Director12014-03-31
REGISTERED NUMBER: SC209236











































ABBREVIATED UNAUDITED ACCOUNTS

FOR THE YEAR ENDED 31 MARCH 2015

FOR

NEUROLOGY PARTNERSHIP LIMITED

NEUROLOGY PARTNERSHIP LIMITED (REGISTERED NUMBER: SC209236)






CONTENTS OF THE ABBREVIATED ACCOUNTS
for the Year Ended 31 March 2015




Page

Company Information 1

Abbreviated Balance Sheet 2

Notes to the Abbreviated Accounts 3

NEUROLOGY PARTNERSHIP LIMITED

COMPANY INFORMATION
for the Year Ended 31 March 2015







DIRECTORS: Dr R Swingler
Dr K El Bouzidi





REGISTERED OFFICE: 20/22 Torphichen Street
Edinburgh
EH3 8JB





REGISTERED NUMBER: SC209236





ACCOUNTANTS: Acumen Accountants and Advisors Limited
20/22 Torphichen Street
Edinburgh
EH3 8JB

NEUROLOGY PARTNERSHIP LIMITED (REGISTERED NUMBER: SC209236)

ABBREVIATED BALANCE SHEET
31 March 2015

2015 2014
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 2 3,979 8,437

CURRENT ASSETS
Debtors 6,155 7,760
Cash at bank and in hand 21,733 27,038
27,888 34,798
CREDITORS
Amounts falling due within one year (1,603 ) 4,757
NET CURRENT ASSETS 29,491 30,041
TOTAL ASSETS LESS CURRENT
LIABILITIES

33,470

38,478

CAPITAL AND RESERVES
Called up share capital 3 100 100
Profit and loss account 33,370 38,378
SHAREHOLDERS' FUNDS 33,470 38,478

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2015.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2015 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each
financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and
which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable
to the company.

The abbreviated accounts have been prepared in accordance with the special provisions of Part 15 of the Companies Act 2006 relating to small companies.


The financial statements were approved by the Board of Directors on 22 December 2015 and were signed on its behalf by:





Dr R Swingler - Director


NEUROLOGY PARTNERSHIP LIMITED (REGISTERED NUMBER: SC209236)

NOTES TO THE ABBREVIATED ACCOUNTS
for the Year Ended 31 March 2015

1. ACCOUNTING POLICIES

Accounting convention
The financial statements have been prepared under the historical cost convention and in accordance with the Financial
Reporting Standard for Smaller Entities (effective April 2008).

Turnover
Turnover represents net invoiced sales of services, excluding value added tax.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Plant and machinery etc - 25% reducing balance

Deferred tax
Deferred tax arises as a result of including items of income and expenditure in taxation computations in periods different
from those in which they are included in the company's accounts. Deferred tax is provided in full on timing differences
which result in an obligation to pay more (or less) tax at a future date, at the average tax rates that are expected to apply
when the timing differences reverse, based on current tax rates and laws.

Deferred tax is not provided on timing differences arising from the revaluation of fixed assets where there is no commitment
to sell the asset.

Deferred tax assets and liabilities are not discounted.

2. TANGIBLE FIXED ASSETS
Total
£   
COST
At 1 April 2014 15,086
Additions 2,021
Disposals (5,153 )
At 31 March 2015 11,954
DEPRECIATION
At 1 April 2014 6,649
Charge for year 1,326
At 31 March 2015 7,975
NET BOOK VALUE
At 31 March 2015 3,979
At 31 March 2014 8,437

3. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2015 2014
value: £    £   
100 Ordinary £1 100 100

NEUROLOGY PARTNERSHIP LIMITED (REGISTERED NUMBER: SC209236)

NOTES TO THE ABBREVIATED ACCOUNTS - continued
for the Year Ended 31 March 2015

4. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 31 March 2015 and 31 March 2014:

2015 2014
£    £   
Dr R Swingler
Balance outstanding at start of year 3,988 445
Amounts advanced 2,255 3,988
Amounts repaid (3,988 ) (445 )
Balance outstanding at end of year 2,255 3,988

The above amount was repaid, in full, within 9 months of the year end.